Oligometastasis in breast cancer—current status and treatment options from a radiation oncology perspective

Evidence from a few small randomized trials and retrospective cohorts mostly including various tumor entities indicates a prolongation of disease free survival (DFS) and overall survival (OS) from local ablative therapies in oligometastatic disease (OMD). However, it is still unclear which patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Piroth, Marc D., Krug, David, Feyer, Petra, Baumann, René, Combs, Stephanie, Duma, Marciana-Nona, Dunst, Jürgen, Fastner, Gerd, Fietkau, Rainer, Guckenberger, Matthias, Haase, Wulf, Harms, Wolfgang, Hehr, Thomas, Sedlmayer, Felix, Souchon, Rainer, Strnad, V., Budach, Wilfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217902/
https://www.ncbi.nlm.nih.gov/pubmed/35527272
http://dx.doi.org/10.1007/s00066-022-01938-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217902/
https://www.ncbi.nlm.nih.gov/pubmed/35527272
http://dx.doi.org/10.1007/s00066-022-01938-x

Ejemplares similares